ARCHIVES

Breast Cancer Incidence Reduced 45% In Tamoxifen Arm Of BCPT; Trial Unblinded

This article is from The Cancer Letter archive.

Vol. 24 No. 14 | April 10, 1998

Download PDF Visit The Full Archive

Related Articles

Children of Male Cancer Survivors Have Highrt Risk of Birth Defects

February 25, 2011

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

January 28, 2011

Research Funding: 30 Groups Sign Letter For Double NCI Budget

January 23, 1998

New Organ Systems Concept Flow Discussed

October 18, 1985

Drug Development: FDA Grants Breakthrough Therapy Designation to CTL019 In ALL

July 11, 2014

NCAB Task Force Urges New Study Section For Clinical Cancer Research, Sees “Crisis”

May 7, 1993